Organic semiconductor formulation

US12245492B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12245492-B2
Application numberUS-202017593921-A
CountryUS
Kind codeB2
Filing dateMar 25, 2020
Priority dateMar 28, 2019
Publication dateMar 4, 2025
Grant dateMar 4, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to novel organic semiconductor (OSC) formulations, to their use for the preparation of OSC layers or OSC patterns in organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photo-detectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, PSC, OPD, OFET and OLED devices comprising an OSC layer or OSC pattern prepared from these OSC formulations.

First claim

Opening claim text (preview).

The invention claimed is: 1. A formulation comprising a p-type organic semiconductor (OSC) and an n-type OSC, the formulation further comprising a first solvent selected from terpenes or terpenoids and a second solvent selected from aromatic, heteroaromatic, or partially unsaturated alicyclic or heterocyclic solvents, wherein the first solvent is selected from the group consisting of β-caryophyllene, vetiveryl acetate, carvacrol, valencene, D-carvone, citral diethyl acetal, verbenone, nerol, menthone, citral, derivatives of the aforementioned, and any combination of the aforementioned, and the p-type OSC is a conjugated polymer having a molecular weight Mn>5000 g/mol. 2. The formulation according to claim 1 , characterized in that the first solvent is selected from the group consisisting of β-caryophyllene, vetiveryl acetate and carvacrol. 3. The formulation according to claim 2 , characterized in that the first solvent is β-caryophyllene. 4. The formulation according to claim 1 , characterized in that the second solvent is selected from the group consisting of alkylated benzene, alkoxylated benzene, indane, alkylated indane, alkoxylated indane, tetralin, alkylated tetralin, naphthalene, alkylated naphthalene, anisole and alkylated anisole. 5. The formulation according to claim 4 , characterized in that the second solvent is selected from the group consisting of 1,5-dimethyltetralin, 1-methylnaphthalene, 1-ethylnaphthalene, 2-ethylnaphthalene, 1,2-dimethylnaphthalene, 1,3-dimethylnaphthalene, 1,4-dimethylnaphthalene, 2,6-dimethylnaphthalene, 2,7-diisopropylnaphthalene and dimethylanisole. 6. The formulation according to claim 5 , characterized in that the second solvent is selected from the group consisting of 1,5-dimethyltetralin, 1-methylnaphthalene and dimethylanisole. 7. The formulation according to claim 1 , characterized in that the concentration of the first solvent is from 2 to 30%, and the concentration of the second solvent is from 50 to 90%. 8. The formulation according to claim 7 , characterized in that the concentration of the p-type OSC is from 1 to 5%, and the concentration of the n-type OSC is from 1 to 5%. 9. The formulation according to claim 1 , characterized in that the formulation does, except for the n-type and p-type OSC, only contain volatile organic compounds. 10. The formulation according to claim 1 , characterized in that the total concentration of all solids is ≤6%. 11. The formulation according to claim 1 , characterized in that the p-type OSC is a conjugated polymer having a molecular weight Mn>5000 g/mol and comprising at least one electron donating unit D and at least one electron accepting unit A, and optionally at least one spacer unit Sp separating a donor unit from an acceptor unit, wherein each donor and acceptor units is directly connected to another donor or acceptor unit or to a spacer unit, and wherein the spacer units, if present, are located between the donor and acceptor units such that a donor unit and an acceptor unit are not directly connected to each other, and wherein all of the donor, acceptor and spacer units are each independently selected from arylene or heteroarylene that has from 5 to 20 ring atoms, is mono- or polycyclic, optionally contains fused rings, and is unsubstituted or substituted by one or more identical or different groups L or R 1 , wherein R 1 is H, F, Cl, CN, -Sp-R C , or straight-chain, branched or cyclic alkyl with 1 to 30 C atoms, in which one or more CH 2 groups are each optionally replaced by —O—, —S—, —C(═O)—, —C(═S)—, —C(═O)—O—, —O—C(═O)—, —NR 0 —, —SiR 0 R 00 —, —CF 2 —, —CR 0 ═CR 00 , —CY 1 ═CY 2 — or —C≡C— in such a manner that O and/or S atoms are not linked directly to one another, and in which one or more H atoms are each optionally replaced by F, Cl, Br, I or CN, or aryl, heteroaryl, arylalkyl, heteroarylalkyl, aryloxy or heteroaryloxy, wherein each of the aforementioned cyclic groups has 5 to 20 ring atoms, is mono- or polycyclic, optionally contains fused rings, and is unsubstituted or substituted by one or more identical or different groups L, L is F, Cl, —NO 2 , —CN, —NC, —NCO, —NCS, —OCN, —SCN, R 0 , OR 0 , SR 0 , —C(═O)X 0 , —C(═O)R 0 , —C(═O)—OR 0 , —O—C(═O)—R 0 , —NH 2 , —NHR 0 , —NR 0 R 00 , —C(═O)NHR 0 , —C(═O)NR 0 R 00 , —SO 3 R 0 , —SO 2 R 0 , —OH, —CF 3 , —SF 5 , or optionally substituted silyl, or carbyl or hydrocarbyl with 1 to 30 C atoms that is optionally substituted and optionally comprises one or more hetero atoms, R 0 , R 00 denote H or straight-chain or branched alkyl with 1 to 20 C atoms that is optionally fluorinated, X 0 is halogen. 12. The formulation according to claim 11 , characterized in that the p-type OSC is a conjugated polymer selected from the following formulae wherein w, x, y and z are each, independently of one another, a non-integer>0 and <1, with x+y=1, and x+y+w+Z=1, n is an integer>1, R 11-19 are H, F, Cl, CN, -Sp-R C , or straight-chain, branched or cyclic alkyl with 1 to 30 C atoms, in which one or more CH 2 groups are each optionally replaced by —O—, —S—, —C(═O)—, —C(═S)—, —C(═O)—O—, —O—C(═O)—, —NR 0 —, —SiR 0 R 00 —, —CF 2 —, —CR 0 —CR 00 , —CY 1 ═CY 2 — or —C≡C— in such a manner that O and/or S atoms are not linked directly to one another, and in which one or more H atoms are each optionally replaced by F, Cl, Br, I or CN, or aryl, heteroaryl, arylalkyl, heteroarylalkyl, aryloxy or heteroaryloxy, wherein each of the aforementioned cyclic groups has 5 to 20 ring atoms, is mono- or polycyclic, optionally contains fused rings, and is unsubstituted or substituted by one or more identical or different groups L, L is F, Cl, —NO 2 , —CN, —NC, —NCO, —NCS, —OCN, —SCN, R 0 , OR 0 , SR 0 , —C(═O)X 0 , —C(═O)R 0 , —C(═O)—OR 0 , —O—C(═O)—R 0 , —NH 2 , —NHR 0 , —NR 0 R 00 , —C(═O)NHR 0 , —C(═O) NR 0 R 00 , —SO 3 R 0 , —SO 2 R 0 , —OH, —CF 3 , —SF 5 , or optionally substituted silyl, or carbyl or hydrocarbyl with 1 to 30 C atoms that is optionally substituted and optionally comprises one or more hetero atoms, —CN, R 0 , —OR 0 , —SR 0 , —C(═O)—R 0 , —C(═O)—OR 0 , —O—C(═O)—R 0 , —O—C(═O)—OR 0 , —C(═O)—NHR 0 , or —C(═O)—NR 0 R 00 , R 0 , R 00 denote H or straight-chain or branched alkyl with 1 to 20 C atoms that is optionally fluorinated, X 0 is halogen, and X 1 , X 2 , X 3 and X 4 denote H, F or Cl. 13. The formulation according to claim 1 , characterized in that the n-type OSC is a small molecule. 14. The formulation according to claim 1 , characterized in that the n-type OSC is a fullerene or a substituted fullerene. 15. The formulation according to claim 14 , characterized in that the n-type OSC is selected from PCBM-C60, PCBM-C70, bis-PCBM-C60, bis-PCBM-C70, ICMA-c60 (1′,4′-dihydro-naphtho [2′,3′: 1,2] [5,6]fullerene-C60), ICBA, oQDM-C60 (1′,4′-dihydro-naphtho [2′,3′: 1,9] [5,6]fullerene-C60-Ih), and bis-oQDM-C60. 16. A method of preparing an organ

Assignees

Inventors

Classifications

  • Organic PV cells · CPC title

  • using printing techniques, e.g. ink-jet printing or screen printing · CPC title

  • comprising bulk heterojunctions, e.g. interpenetrating networks of donor and acceptor material domains · CPC title

  • comprising substituents, e.g. PCBM · CPC title

  • Fullerenes, e.g. C60 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12245492B2 cover?
The invention relates to novel organic semiconductor (OSC) formulations, to their use for the preparation of OSC layers or OSC patterns in organic electronic (OE) devices, especially organic photovoltaic (OPV) devices, perovskite-based solar cell (PSC) devices, organic photo-detectors (OPD), organic field effect transistors (OFET) and organic light emitting diodes (OLED), and to OE, OPV, PSC, O…
Who is the assignee on this patent?
Raynergy Tek Inc
What technology area does this patent fall under?
Primary CPC classification H10K71/15. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).